CTLA4 and melanoma: Similarly, Chen et al. also showed significantly higher CD8 T cell density in baseline and particularly, in early on treatment biopsies from melanoma patients responding to sequential anti-CTLA-4 and anti-PD-1 therapy (Chen et al. 2016).